| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-18 |
| | 10-K | 10-K | 10-K | S-1 |
| Total revenues | 158.8 | 123.8 | 5.4 | |
| Total revenues growth | 28.3% | 2194.2% | | |
| Gross profit | 70.2 | 39.8 | 4.2 | |
| Gross margin | 44.2% | 32.2% | 78.1% | |
| |
| Operating expenses: | | | | |
| Sales and marketing | 16.0 | 10.6 | | |
| Research and development | 7.9 | 7.6 | 0.9 | |
| General and administrative | 48.8 | 52.3 | 4.9 | |
| Depreciation and amortization | 16.1 | 13.0 | 0.3 | |
| |
| Stock-based compensation | | | | |
| Impairment of goodwill, intangible assets, and other long-lived assets | 114.1 | 297.9 | | |
| Acquisition, integration, and transformation costs | 22.2 | 36.3 | | |
| Total operating expenses | 231.5 | 419.8 | 6.1 | |
| Loss from operations | -161.4 | -380.0 | -1.9 | |
| Operating margin | -101.6% | -306.9% | -35.7% | |
| |
| Other expense: | | | | |
| Interest expense | -26.5 | -19.5 | -0.1 | |
| Total other expense | -70.9 | 37.2 | -0.1 | |
| Income tax benefit (expense) | 9.4 | 2.4 | 0.1 | |
| Net loss | -222.9 | -340.9 | -2.2 | |
| Less: net income (loss) attributable to noncontrolling interests | 0.1 | 0.1 | | |
| Net loss attributable to UpHealth, Inc. | -223.0 | -341.0 | -2.2 | |
| |
| Net loss per share attributable to UpHealth, Inc.: | | | | |
| Basic (in dollars per share) | ($15.17) | ($31.86) | ($0.04) | |
| Diluted (in dollars per share) | ($15.17) | ($31.86) | ($0.04) | |
| |
| Weighted average shares outstanding: | | | | |
| Basic (in shares) | 14.7 | 10.7 | 52.3 | |
| Diluted (in shares) | 14.7 | 10.7 | 52.3 | |